Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Hu-Yang Xie"'
Autor:
Yun-Jie Yang, Guo-Wen Lin, Gao-Xiang Li, Bo Dai, Ding-Wei Ye, Jun-Long Wu, Hu-Yang Xie, Yao Zhu
Publikováno v:
Asian Journal of Andrology, Vol 20, Iss 2, Pp 184-188 (2018)
Abiraterone acetate is approved for the treatment of castration-resistant prostate cancer (CRPC); however, its effects vary. An accurate prediction model to identify patient groups that will benefit from abiraterone treatment is therefore urgently re
Externí odkaz:
https://doaj.org/article/17b3c03fbe1b44a4b00c2f065c78b135
Autor:
Yi-jun, Shen, Xiao-jie, Bian, Hu-yang, Xie, Yao, Zhu, Hai-liang, Zhang, Bo, Dai, Shi-lin, Zhang, Xu-dong, Yao, Ding-wei, Ye
Publikováno v:
Zhonghua wai ke za zhi [Chinese journal of surgery]. 50(6)
To compare docetaxel plus prednisone with mitoxantrone plus prednisone as first-line chemotherapy for metastatic hormone-refractory prostate cancer (mHRPC).From January 2007 through August 2010, 62 patients with mHRPC received 5 mg of prednisone twic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::62c258a7cdfb09b0949fd53d251f590f
https://pubmed.ncbi.nlm.nih.gov/22943949
https://pubmed.ncbi.nlm.nih.gov/22943949